Despite the fact that the U.S. spends more per capita on health care than any other nation in the world, 1 a significant proportion of Americans still lack access to high-quality, modern cardiovascular care. In fact, recent national data suggests that only about two-thirds of Medicare patients presenting with ST-segment elevation myocardial infarction receive revascularization. 2, 3 These numbers are even lower in rural communities, 4, 5 and are likely part of the reason why patients in rural areas have worse outcomes after suffering an acute myocardial infarction (MI) than those in more urban areas. 6 In this light, there is an urgent need to ensure the adequate availability of high-value invasive cardiac services, particularly in rural or semi-rural areas of the country. With these important concerns as a starting point, Horwitz et al examined the introduction of diagnostic angiography, percutaneous coronary intervention, and coronary artery bypass grafting services in the United States between 1996 and 2008. The authors studied whether new offerings of these services were leading to an expansion of access to care in areas which were previously un-or under-served. 7 Simply put, were the new services being offered in the places that needed them most?
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by guest on April 20, 2017 http://circ.ahajournals.org/ Downloaded from four percentage points. All told, these expansions did little to address the uneven access to modern cardiovascular care that is a rightful concern for patients and policymakers.
The Problem of Underuse
The most straightforward message of this paper is that, even in this technologically advanced era of medicine, we still have inadequate access to care across wide areas of the country. 
The Problem of Overuse
This study is also important, however, because it elucidates one possible contributor to the flip side of the supply problem: overuse. There is increasing evidence that invasive cardiac services are often overused -there have been reports of inappropriately high rates of PCI for stable angina despite a lack of evidence for its benefit in this population, 11 for example, not to mention accusations of frankly fraudulent overuse of PCI in a growing number of high-profile cases around the country. However, prior reports have often focused on the clinical drivers of overuse: [11] [12] [13] postulated contributors include overuse of stress testing, a lack of trust in many have called for increasing regionalization of cardiac services, and a growi in ng ng n n num m mbe be ber r r of of of tate and federal collaboratives are designing and implementing networks for care for acute MI, suggest that the financial incentives to adopt new services in places in which they already exist are clearly powerful enough to encourage hospitals to do so, leading to waste. Given the current relative lack of price competition in health care, it is likely that this is inefficient from a societal perspective, though it may be highly lucrative for the hospitals involved.
Though this study did not directly examine the impact of increased supply on the use of cardiac services, prior research suggests that the two are likely linked. There is tremendous geographic variation in the use of angiography across the country, and the variation is largely linked to the degree of discretionary use across communities. 14, 15 Supply may drive this variation: there is a strong association between the number of catheterization laboratories per capita and the use of angiography and revascularization in a population, and this is unrelated to clinical need (as measured by hospitalizations for acute MI). 16 Additional research shows that the opening of specialty cardiac hospitals is associated with higher population-based rates of coronary revascularization within a hospital referral region despite no differences in the underlying health of the patient population. 17 are clearly powerful enough to encourage hospitals to do so, leading to waste. G Giv i iven e e t the he he c c cur ur urre rent elative lack of price competition in health care, it is likely that this is inefficient from a societal pe ers rs spe pe pect ct ctiv iv ive, e, e, t t tho h ug ug ugh h h it may be highly lucrative fo o or r r th h he hospitals in nvo v v lv ved ed ed. .
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Right-Sizing Cardiac Services
Our invasive cardiac capabilities are too limited in some places and too expansive in others.
Generally, in a competitive market, economics tells us that this mismatch should be remedied.
Oversupply (i.e. in urban areas) should lead to lower prices, while undersupply (i.e. in rural areas) should lead to higher prices, and therefore more opportunity for profit, leading to more market entry. Such market mechanisms would match the needs of the population with the services needed. This is clearly not currently happening.
So why hasn't the market for invasive cardiac services already right-sized itself, and what are the policy and clinical fixes for this problem? A definitive answer is beyond the scope of this particular investigation, but the authors' work raises a set of interesting possibilities.
The reasons behind underuse are likely largely economic. Invasive cardiac services have high fixed costs, and for small or rural hospitals, these costs may be prohibitive. Even if these services could be financially viable in the long run, many small and rural hospitals also have more difficulty securing access to capital with which to adopt the technologies in the short run.
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by guest on April 20, 2017 http://circ.ahajournals.org/ Downloaded from invasive cardiac services may be of benefit, 20 as well as increasing use of quality metrics that reward hospitals for appropriately providing revascularization, may be promising strategies to reduce underuse of these technologies in areas in which it currently occurs.
In terms of over-use, the market has likely failed to limit supply because of our fee-forservice reimbursement models. The financial motivations are simple -if hospitals can add highmargin services and technologies, it behooves them to do so, whether or not that addition serves a useful clinical need. There are presently few financial checks on overuse, though policy strategies such as shifting payment models towards bundled payments and Accountable Care
Organizations may change that dynamic. Further, there are few clinical checks on overuse, because unlike more typical consumer goods, the individual does not directly control his or her consumption of services -rather, his or her physicians control this consumption. The growing use of appropriateness criteria 11 and quality metrics may represent promising strategies to reduce overuse using clinical tools.
If we hope to continue the trend of improving cardiovascular outcomes nationwide, 2 we need to start thinking about U.S. healthcare as a system rather than as a collection of individual actors. Right now, while PCI is rampantly overused in some areas of the country, there are entire communities that are being left without access to invasive cardiac services at all. Ironically, both overuse and underuse are likely associated with worse clinical outcomes.
We need to right-size the use of invasive cardiac services in the U.S. Currently, our policy and reimbursement climate are failing to remedy the problem. Highly practical health services research in general, and this paper in particular, have an extremely important role to play in leveraging data to inform policy decisions that could ultimately benefit hundreds of thousands of Americans.
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